期刊
CLINICAL NUCLEAR MEDICINE
卷 40, 期 3, 页码 258-259出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000606
关键词
FDG; PET/CT; ipilimumab; melanoma; hepatitis